Published in Isr J Med Sci on January 01, 1981
Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity (1999) 7.78
EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling. Cell (1989) 5.68
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature (1996) 4.04
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene (2001) 3.96
Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor. Mol Cell (1999) 3.73
Negative cooperativity in regulatory enzymes. Proc Natl Acad Sci U S A (1969) 3.38
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. J Med Chem (1989) 3.02
Transglutaminase is essential in receptor-mediated endocytosis of alpha 2-macroglobulin and polypeptide hormones. Nature (1980) 2.82
Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors. Science (1988) 2.35
Metal-binding sites of concanavalin A and their role in the binding of alpha-methyl d-glucopyranoside. Biochem J (1968) 2.17
Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases. Proc Natl Acad Sci U S A (1998) 2.15
The interaction of concanavalin A with methyl alpha-D-glucopyranoside. Biochim Biophys Acta (1968) 2.09
Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol Cell Biol (2001) 2.08
Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science (1994) 1.96
Mode of coupling between the beta-adrenergic receptor and adenylate cyclase in turkey erythrocytes. Biochemistry (1978) 1.87
The effect of tyrosine-specific protein phosphorylation on the assembly of adherens-type junctions. EMBO J (1992) 1.85
Half-of-the-sites reactivity and the conformational states of cytidine triphosphate synthetase. Biochemistry (1971) 1.76
Cisplatin induces PKB/Akt activation and p38(MAPK) phosphorylation of the EGF receptor. Oncogene (2006) 1.72
Tyrphostins inhibit epidermal growth factor (EGF)-receptor tyrosine kinase activity in living cells and EGF-stimulated cell proliferation. J Biol Chem (1989) 1.72
Epidermal-growth-factor-dependent activation of the src-family kinases. Eur J Biochem (1994) 1.68
Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins. Endocrinology (1997) 1.68
Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res (1994) 1.63
The role of negative cooperativity and half-of-the-sites reactivity in enzyme regulation. Curr Top Cell Regul (1976) 1.62
Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity. J Biol Chem (2000) 1.61
Flk-1 as a target for tumor growth inhibition. Cancer Res (1996) 1.56
Signal therapy for RAS-induced cancers in combination of AG 879 and PP1, specific inhibitors for ErbB2 and Src family kinases, that block PAK activation. Cancer J (2001) 1.49
Ligand specificity and characteristics of the beta-adrenergic receptor in turkey erythrocyte plasma membranes. J Mol Biol (1975) 1.43
An anti-Ras cancer potential of PP1, an inhibitor specific for Src family kinases: in vitro and in vivo studies. Cancer J (2001) 1.42
Adenylate cyclase activation by the beta-adrenergic receptors as a diffusion-controlled process. Biochemistry (1979) 1.42
Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors. Oncogene (1999) 1.41
The binding characteristics and number of beta-adrenergic receptors on the turkey erythrocyte. Proc Natl Acad Sci U S A (1974) 1.41
The control of adenylate cyclase by calcium in turkey erythrocyte ghosts. J Biol Chem (1975) 1.36
Dimerization of Ste5, a mitogen-activated protein kinase cascade scaffold protein, is required for signal transduction. Proc Natl Acad Sci U S A (1996) 1.32
Evidence for participation of transglutaminase in receptor-mediated endocytosis. Proc Natl Acad Sci U S A (1980) 1.32
PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine. Circulation (1998) 1.31
Phosphorylation of the S. cerevisiae Cdc25 in response to glucose results in its dissociation from Ras. Nature (1993) 1.30
Determination of submicro quantities of ammonia. Anal Biochem (1970) 1.29
Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins. J Biol Chem (1993) 1.27
Tyrphostins. 5. Potent inhibitors of platelet-derived growth factor receptor tyrosine kinase: structure-activity relationships in quinoxalines, quinolines, and indole tyrphostins. J Med Chem (1996) 1.27
The allosteric activation of mammalian alpha-amylase by chloride. Eur J Biochem (1974) 1.25
Tyrphostins. 2. Heterocyclic and alpha-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases. J Med Chem (1991) 1.22
Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells. Am J Physiol (1991) 1.20
The subunit structure and subunit interactions of cytidine triphosphate synthetase. J Biol Chem (1970) 1.19
Binding of lanthanides and of divalent metal ions to porcine trypsin. Biochemistry (1974) 1.17
Isolation of hyperactive mutants of the MAPK p38/Hog1 that are independent of MAPK kinase activation. J Biol Chem (2001) 1.17
The activation of adenylate cyclase by guanyl nucleotides in Saccharomyces cerevisiae is controlled by the CDC25 start gene product. Mol Cell Biol (1987) 1.17
Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation. Mol Cell Biol (1998) 1.14
Cytidine triphosphate synthetase. Covalent intermediates and mechanisms of action. Biochemistry (1971) 1.14
An accurate method for determination of receptor-ligand and enzyme-inhibitor dissociation constants from displacement curves. Proc Natl Acad Sci U S A (1987) 1.11
Role of an allosteric effector. Guanosine triphosphate activation in cytosine triphosphate synthetase. Biochemistry (1972) 1.10
Substrate competitive inhibitors of IGF-1 receptor kinase. Biochemistry (2000) 1.10
Stereospecific binding of propranolol and catecholamines to the beta-adrenergic receptor. Proc Natl Acad Sci U S A (1974) 1.09
Coupling of a single adenylate cyclase to two receptors: adenosine and catecholamine. Biochemistry (1978) 1.09
Phosphorylation site-specific inhibition of platelet-derived growth factor beta-receptor autophosphorylation by the receptor blocking tyrphostin AG1296. Biochemistry (1997) 1.09
Synergistic activation of adenylate cyclase by guanylyl imidophosphate and epinephrine. Biochemistry (1976) 1.09
Activation of phospholipase C in human B cells is dependent on tyrosine phosphorylation. J Clin Invest (1991) 1.09
Human glioblastoma xenografts overexpressing a tumor-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor. J Neurosurg (2001) 1.09
Signal transduction by a nondissociable heterotrimeric yeast G protein. Proc Natl Acad Sci U S A (2000) 1.08
Mode of coupling between hormone receptors and adenylate cyclase elucidated by modulation of membrane fluidity. Nature (1978) 1.07
Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells. Cancer Res (1996) 1.07
Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinase. Biochem Pharmacol (2006) 1.07
Beta-adrenergic receptors and their mode of coupling to adenylate cyclase. Physiol Rev (1986) 1.07
Cloning of the STE5 gene of Saccharomyces cerevisiae as a suppressor of the mating defect of cdc25 temperature-sensitive mutants. Proc Natl Acad Sci U S A (1993) 1.06
Ligand-induced dimer-to-tetramer transformation in cytosine triphosphate synthetase. Biochemistry (1972) 1.05
The tyrosine kinase inhibitor tyrphostin blocks the cellular actions of nerve growth factor. Biochemistry (1993) 1.05
Negative co-operativity in clustered receptors as a possible basis for membrane action. J Theor Biol (1974) 1.05
Hormone-receptor--adenylate cyclase interactions. FEBS Lett (1979) 1.04
Adenosine receptor permanently coupled to turkey erythrocyte adenylate cyclase. Biochemistry (1979) 1.03
Platelet-derived growth factor requires epidermal growth factor receptor to activate p21-activated kinase family kinases. J Biol Chem (2001) 1.03
Selective interactions of transforming and normal abl proteins with ATP, tyrosine-copolymer substrates, and tyrphostins. J Biol Chem (1992) 1.02
Status of p53 in human cancer cells does not predict efficacy of CHK1 kinase inhibitors combined with chemotherapeutic agents. Oncogene (2010) 1.00
The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice. Cancer Res (1991) 1.00
In vitro reconstitution of cdc25 regulated S. cerevisiae adenylyl cyclase and its kinetic properties. EMBO J (1990) 0.98
Molecular basis of negative co-operativity in rabbit muscle glyceraldehyde-3-phosphate dehydrogenase. J Mol Biol (1974) 0.98
Reconstitution of beta-adrenergic receptor with components of adenylate cyclase. EMBO J (1984) 0.97
Subunit neighbor interactions in enzyme kinetics: half-of-the-sites reactivity in a dimer. Proc Natl Acad Sci U S A (1980) 0.97
The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockers. J Cell Biol (1991) 0.97
Reconstitution of membrane receptor systems. Biochim Biophys Acta (1985) 0.96
Inhibition of insulin-dependent lipogenesis and anti-lipolysis by protein tyrosine kinase inhibitors. EMBO J (1989) 0.96
The activation of adenylate cyclase by 1-epinephrine and guanylylimidodiphosphate and its reversal by 1-epinephrine and GTP. FEBS Lett (1977) 0.95
Kinetics of inhibition by tyrphostins of the tyrosine kinase activity of the epidermal growth factor receptor and analysis by a new computer program. Mol Pharmacol (1994) 0.95
Regulation of adenylate cyclase by hormones and G-proteins. FEBS Lett (1987) 0.95
The mode of coupling of adenylate cyclase to hormone receptors and its modulation by GTP. Biochem Pharmacol (1978) 0.94
Adenylate cyclase activity of NIH 3T3 cells morphologically transformed by ras genes. FEBS Lett (1986) 0.94
Kinetics of interaction between beta-receptors, GTP protein, and the catalytic unit of turkey erythrocyte adenylate cyclase. Proc Natl Acad Sci U S A (1982) 0.93
Formulation and delivery mode affect disposition and activity of tyrphostin-loaded nanoparticles in the rat carotid model. Arterioscler Thromb Vasc Biol (2001) 0.93
Transmembrane signalling to adenylate cyclase in mammalian cells and in Saccharomyces cerevisiae. Trends Biochem Sci (1988) 0.93
Stimulatory GTP regulatory unit Ns and the catalytic unit of adenylate cyclase are tightly associated: mechanistic consequences. Proc Natl Acad Sci U S A (1984) 0.93
Identity and properties of the chloride effector binding site in hog pancreatic alpha-amylase. Biochemistry (1976) 0.93
Potential (18)F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase. Nucl Med Biol (2001) 0.93
The role of GTP in the activation of adenylate cyclase. Biochem Biophys Res Commun (1977) 0.92
Guanine nucleotide regulation of adenylate cyclase in permeabilized cells of Saccharomyces cerevisiae. Biochim Biophys Acta (1988) 0.92
Inhibition of Cdk2 activation by selected tyrphostins causes cell cycle arrest at late G1 and S phase. Exp Cell Res (1998) 0.91
Quantitative aspects of allosteric mechanisms. Mol Biol Biochem Biophys (1978) 0.91
An irreversible blocker for the beta-adrenergic receptor. Biochem Biophys Res Commun (1976) 0.91
Kinetic model of the epidermal growth factor (EGF) receptor tyrosine kinase and a possible mechanism of its activation by EGF. J Biol Chem (1992) 0.91
Half-of-the-sites and all-of-the-sites reactivity in rabbit muscle glyceraldehyde 3-phosphate dehydrogenase. J Mol Biol (1974) 0.90
Tyrphostin-induced inhibition of p210bcr-abl tyrosine kinase activity induces K562 to differentiate. Blood (1993) 0.90